Notices. Notice of application
291 words·~1 min read·
/register/2020/04/07/2020-07273·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-618] Importer of Controlled Substances Application: Almac Clinical Services Incorp
(ACSI)ACTION: Notice of application. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 7, 2020. Such persons may also file a written request for a hearing on the application on or before May 7, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to:
(1)Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and
(2)Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on March 6, 2020, Almac Clinical Services Incorp,
(ACSI)25 Fretz Road, Souderton, Pennsylvania, 18964, applied to be registered as an importer of the following basic class(es) of controlled substances: Controlled substance Drug code Schedule Psilocybin 7437 I Oxycodone 9143 II Hydromorphone 9150 II Morphine 9300 II Tapentadol 9780 II Fentanyl 9801 II The company plans to import the listed controlled substances in dosage form to conduct clinical trials. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under to 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA-approved or non-approved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2020-07273 Filed 4-6-20; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources